STOCK TITAN

[Form 4] Viking Therapeutics, Inc Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Hamilton Beach Brands Holding Co. (HBB) filed a Form 4 for director Alfred M. Rankin, Jr. covering a single transaction on 07/01/2025. Acting as trustee for a family trust, Rankin acquired 2,156 Class A common shares classified as “Required Shares” under the company’s Non-Employee Directors’ Equity Compensation Plan; footnote 2 confirms the shares were received with no cash consideration (price N/A).

After the award, the trust’s position rose to 361,551 shares. The filing also lists other indirect holdings: 14,160 shares in an IRA for Rankin and trusts holding 11,076 and 69,872 shares for family members, for which he disclaims beneficial ownership. No derivative securities, sales, or additional acquisitions were reported.

The transaction reflects routine board compensation rather than an open-market buy and represents a modest percentage of Rankin’s existing indirect holdings, implying limited immediate market impact but continued insider alignment with shareholder interests.

Hamilton Beach Brands Holding Co. (HBB) ha presentato un Modulo 4 per il direttore Alfred M. Rankin, Jr., relativo a una singola transazione avvenuta il 01/07/2025. In qualità di fiduciario per un trust familiare, Rankin ha acquisito 2.156 azioni ordinarie di Classe A classificate come “Azioni Obbligatorie” secondo il Piano di Compensazione Azionaria per Direttori Non Dipendenti della società; la nota 2 conferma che le azioni sono state ricevute senza alcun corrispettivo in denaro (prezzo N/D).

Dopo l’assegnazione, la posizione del trust è salita a 361.551 azioni. La dichiarazione include anche altre partecipazioni indirette: 14.160 azioni in un IRA per Rankin e trust che detengono rispettivamente 11.076 e 69.872 azioni per membri della famiglia, per le quali egli nega la titolarità effettiva. Non sono stati segnalati strumenti derivati, vendite o ulteriori acquisizioni.

La transazione riflette una normale compensazione del consiglio piuttosto che un acquisto sul mercato aperto e rappresenta una percentuale modesta delle partecipazioni indirette già detenute da Rankin, suggerendo un impatto di mercato immediato limitato ma un continuo allineamento degli interessi interni con quelli degli azionisti.

Hamilton Beach Brands Holding Co. (HBB) presentó un Formulario 4 para el director Alfred M. Rankin, Jr. que cubre una sola transacción realizada el 01/07/2025. Actuando como fideicomisario de un fideicomiso familiar, Rankin adquirió 2,156 acciones ordinarias Clase A clasificadas como “Acciones Requeridas” bajo el Plan de Compensación de Capital para Directores No Empleados de la empresa; la nota al pie 2 confirma que las acciones se recibieron sin consideración en efectivo (precio N/A).

Después de la adjudicación, la posición del fideicomiso aumentó a 361,551 acciones. La presentación también lista otras participaciones indirectas: 14,160 acciones en una IRA para Rankin y fideicomisos que poseen 11,076 y 69,872 acciones para miembros de la familia, sobre las cuales él renuncia a la propiedad beneficiaria. No se reportaron valores derivados, ventas ni adquisiciones adicionales.

La transacción refleja una compensación rutinaria del consejo en lugar de una compra en el mercado abierto y representa un porcentaje modesto de las participaciones indirectas existentes de Rankin, lo que implica un impacto inmediato limitado en el mercado pero una continua alineación interna con los intereses de los accionistas.

Hamilton Beach Brands Holding Co. (HBB)는 이사 Alfred M. Rankin, Jr.에 대해 2025년 7월 1일 단일 거래를 포함하는 Form 4를 제출했습니다. Rankin은 가족 신탁의 수탁자로서 회사의 비임원 이사 주식 보상 계획에 따라 “필수 주식”으로 분류된 2,156주 클래스 A 보통주를 취득했으며, 각주 2는 해당 주식이 현금 대가 없이(가격 없음) 수령되었음을 확인합니다.

수여 후 신탁의 보유 주식은 361,551주로 증가했습니다. 제출서류에는 Rankin을 위한 IRA에 보유 중인 14,160주와 가족 구성원을 위한 신탁이 보유한 11,076주69,872주의 간접 보유도 포함되어 있으며, 그는 이에 대한 실질적 소유권을 부인합니다. 파생 증권, 매도 또는 추가 취득은 보고되지 않았습니다.

이번 거래는 공개 시장 매수가 아닌 일상적인 이사회 보상을 반영하며, Rankin의 기존 간접 보유 주식 중 소규모 비율에 해당하여 즉각적인 시장 영향은 제한적이지만 내부자와 주주 간 이해관계가 지속적으로 일치함을 의미합니다.

Hamilton Beach Brands Holding Co. (HBB) a déposé un formulaire 4 pour le directeur Alfred M. Rankin, Jr. concernant une seule transaction réalisée le 01/07/2025. Agissant en tant que fiduciaire pour un trust familial, Rankin a acquis 2 156 actions ordinaires de classe A classées comme « Actions requises » dans le cadre du Plan de rémunération en actions des administrateurs non salariés de la société ; la note 2 confirme que les actions ont été reçues sans contrepartie en espèces (prix N/A).

Après l’attribution, la position du trust est passée à 361 551 actions. Le dépôt mentionne également d’autres participations indirectes : 14 160 actions dans un IRA pour Rankin et des trusts détenant 11 076 et 69 872 actions pour des membres de la famille, dont il décline la propriété bénéficiaire. Aucun titre dérivé, vente ou acquisition supplémentaire n’a été signalé.

La transaction reflète une rémunération habituelle du conseil plutôt qu’un achat sur le marché ouvert et représente un pourcentage modeste des participations indirectes existantes de Rankin, laissant présager un impact immédiat limité sur le marché mais un alignement continu des intérêts internes avec ceux des actionnaires.

Hamilton Beach Brands Holding Co. (HBB) reichte ein Formular 4 für den Direktor Alfred M. Rankin, Jr. ein, das eine einzelne Transaktion am 01.07.2025 abdeckt. Als Treuhänder eines Familientrusts erwarb Rankin 2.156 Class A Stammaktien, die im Rahmen des Aktienvergütungsplans für nicht angestellte Direktoren als „Erforderliche Aktien“ klassifiziert sind; Fußnote 2 bestätigt, dass die Aktien ohne Bargeldzahlung (Preis nicht verfügbar) erhalten wurden.

Nach der Zuteilung stieg die Position des Trusts auf 361.551 Aktien. Die Meldung listet auch weitere indirekte Beteiligungen auf: 14.160 Aktien in einem IRA für Rankin sowie Trusts, die 11.076 und 69.872 Aktien für Familienmitglieder halten, für die er das wirtschaftliche Eigentum bestreitet. Keine Derivate, Verkäufe oder weitere Erwerbe wurden gemeldet.

Die Transaktion spiegelt eine routinemäßige Vorstandsvergütung wider und keinen Kauf am offenen Markt und stellt einen bescheidenen Prozentsatz von Rankins bestehenden indirekten Beteiligungen dar, was auf eine begrenzte unmittelbare Marktauswirkung, aber eine fortgesetzte interne Ausrichtung an den Interessen der Aktionäre hinweist.

Positive
  • Director’s indirect stake increased by 2,156 shares, signaling continued insider alignment.
  • No insider sales were reported, removing potential negative supply pressure.
Negative
  • Grant size is immaterial versus prior holdings, offering limited informational value to investors.
  • Shares were received at no cash cost, so the transaction carries less conviction than an open-market purchase.

Insights

TL;DR: Modest equity-plan grant to director; minimal dollar magnitude; neutral share-supply effect.

The 2,156-share award is a standard non-cash issuance under HBB’s director compensation plan. It raises Alfred Rankin’s trust holdings to 361,551 shares but does not involve open-market buying, so signalling value is weaker than a cash purchase. The absence of sales is mildly positive, yet the small size relative to existing ownership limits materiality. Overall market impact is neutral.

Hamilton Beach Brands Holding Co. (HBB) ha presentato un Modulo 4 per il direttore Alfred M. Rankin, Jr., relativo a una singola transazione avvenuta il 01/07/2025. In qualità di fiduciario per un trust familiare, Rankin ha acquisito 2.156 azioni ordinarie di Classe A classificate come “Azioni Obbligatorie” secondo il Piano di Compensazione Azionaria per Direttori Non Dipendenti della società; la nota 2 conferma che le azioni sono state ricevute senza alcun corrispettivo in denaro (prezzo N/D).

Dopo l’assegnazione, la posizione del trust è salita a 361.551 azioni. La dichiarazione include anche altre partecipazioni indirette: 14.160 azioni in un IRA per Rankin e trust che detengono rispettivamente 11.076 e 69.872 azioni per membri della famiglia, per le quali egli nega la titolarità effettiva. Non sono stati segnalati strumenti derivati, vendite o ulteriori acquisizioni.

La transazione riflette una normale compensazione del consiglio piuttosto che un acquisto sul mercato aperto e rappresenta una percentuale modesta delle partecipazioni indirette già detenute da Rankin, suggerendo un impatto di mercato immediato limitato ma un continuo allineamento degli interessi interni con quelli degli azionisti.

Hamilton Beach Brands Holding Co. (HBB) presentó un Formulario 4 para el director Alfred M. Rankin, Jr. que cubre una sola transacción realizada el 01/07/2025. Actuando como fideicomisario de un fideicomiso familiar, Rankin adquirió 2,156 acciones ordinarias Clase A clasificadas como “Acciones Requeridas” bajo el Plan de Compensación de Capital para Directores No Empleados de la empresa; la nota al pie 2 confirma que las acciones se recibieron sin consideración en efectivo (precio N/A).

Después de la adjudicación, la posición del fideicomiso aumentó a 361,551 acciones. La presentación también lista otras participaciones indirectas: 14,160 acciones en una IRA para Rankin y fideicomisos que poseen 11,076 y 69,872 acciones para miembros de la familia, sobre las cuales él renuncia a la propiedad beneficiaria. No se reportaron valores derivados, ventas ni adquisiciones adicionales.

La transacción refleja una compensación rutinaria del consejo en lugar de una compra en el mercado abierto y representa un porcentaje modesto de las participaciones indirectas existentes de Rankin, lo que implica un impacto inmediato limitado en el mercado pero una continua alineación interna con los intereses de los accionistas.

Hamilton Beach Brands Holding Co. (HBB)는 이사 Alfred M. Rankin, Jr.에 대해 2025년 7월 1일 단일 거래를 포함하는 Form 4를 제출했습니다. Rankin은 가족 신탁의 수탁자로서 회사의 비임원 이사 주식 보상 계획에 따라 “필수 주식”으로 분류된 2,156주 클래스 A 보통주를 취득했으며, 각주 2는 해당 주식이 현금 대가 없이(가격 없음) 수령되었음을 확인합니다.

수여 후 신탁의 보유 주식은 361,551주로 증가했습니다. 제출서류에는 Rankin을 위한 IRA에 보유 중인 14,160주와 가족 구성원을 위한 신탁이 보유한 11,076주69,872주의 간접 보유도 포함되어 있으며, 그는 이에 대한 실질적 소유권을 부인합니다. 파생 증권, 매도 또는 추가 취득은 보고되지 않았습니다.

이번 거래는 공개 시장 매수가 아닌 일상적인 이사회 보상을 반영하며, Rankin의 기존 간접 보유 주식 중 소규모 비율에 해당하여 즉각적인 시장 영향은 제한적이지만 내부자와 주주 간 이해관계가 지속적으로 일치함을 의미합니다.

Hamilton Beach Brands Holding Co. (HBB) a déposé un formulaire 4 pour le directeur Alfred M. Rankin, Jr. concernant une seule transaction réalisée le 01/07/2025. Agissant en tant que fiduciaire pour un trust familial, Rankin a acquis 2 156 actions ordinaires de classe A classées comme « Actions requises » dans le cadre du Plan de rémunération en actions des administrateurs non salariés de la société ; la note 2 confirme que les actions ont été reçues sans contrepartie en espèces (prix N/A).

Après l’attribution, la position du trust est passée à 361 551 actions. Le dépôt mentionne également d’autres participations indirectes : 14 160 actions dans un IRA pour Rankin et des trusts détenant 11 076 et 69 872 actions pour des membres de la famille, dont il décline la propriété bénéficiaire. Aucun titre dérivé, vente ou acquisition supplémentaire n’a été signalé.

La transaction reflète une rémunération habituelle du conseil plutôt qu’un achat sur le marché ouvert et représente un pourcentage modeste des participations indirectes existantes de Rankin, laissant présager un impact immédiat limité sur le marché mais un alignement continu des intérêts internes avec ceux des actionnaires.

Hamilton Beach Brands Holding Co. (HBB) reichte ein Formular 4 für den Direktor Alfred M. Rankin, Jr. ein, das eine einzelne Transaktion am 01.07.2025 abdeckt. Als Treuhänder eines Familientrusts erwarb Rankin 2.156 Class A Stammaktien, die im Rahmen des Aktienvergütungsplans für nicht angestellte Direktoren als „Erforderliche Aktien“ klassifiziert sind; Fußnote 2 bestätigt, dass die Aktien ohne Bargeldzahlung (Preis nicht verfügbar) erhalten wurden.

Nach der Zuteilung stieg die Position des Trusts auf 361.551 Aktien. Die Meldung listet auch weitere indirekte Beteiligungen auf: 14.160 Aktien in einem IRA für Rankin sowie Trusts, die 11.076 und 69.872 Aktien für Familienmitglieder halten, für die er das wirtschaftliche Eigentum bestreitet. Keine Derivate, Verkäufe oder weitere Erwerbe wurden gemeldet.

Die Transaktion spiegelt eine routinemäßige Vorstandsvergütung wider und keinen Kauf am offenen Markt und stellt einen bescheidenen Prozentsatz von Rankins bestehenden indirekten Beteiligungen dar, was auf eine begrenzte unmittelbare Marktauswirkung, aber eine fortgesetzte interne Ausrichtung an den Interessen der Aktionäre hinweist.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lian Brian

(Last) (First) (Middle)
C/O VIKING THERAPEUTICS, INC.
9920 PACIFIC HEIGHTS BLVD, SUITE 350

(Street)
SAN DIEGO CA 92121

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Viking Therapeutics, Inc. [ VKTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.00001 per share 07/02/2025 A 48,333(1) A $0 2,414,903 D
Common Stock, par value $0.00001 per share 07/03/2025 S 26,889(2) D $27.8044(3) 2,388,014 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2025, 33.33% of which vested on July 2, 2025 upon the achievement of a non-financial performance goal.
2. These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to the performance restricted stock unit award described in Footnote 1.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.70 to $27.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote.
/s/ Michael Morneau, as Attorney-in-Fact 07/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Hamilton Beach Brands (HBB) shares did Alfred M. Rankin acquire?

He acquired 2,156 Class A common shares on 07/01/2025.

What is Alfred Rankin’s total trust holding after the Form 4 transaction?

The trust now holds 361,551 HBB shares.

Was any cash paid for the shares reported in this Form 4?

No. Footnote 2 states “N/A” price; the shares were awarded under the director equity plan.

Were any derivative securities or share sales disclosed in the filing?

No derivative securities or sales were reported; the filing covers a single share acquisition.

Does the filing mention other indirect holdings by Alfred Rankin?

Yes. He indirectly holds 14,160 shares in an IRA and serves as trustee for trusts holding 11,076 and 69,872 shares, which he disclaims.
Viking Therapeutics Inc

NASDAQ:VKTX

VKTX Rankings

VKTX Latest News

VKTX Latest SEC Filings

VKTX Stock Data

3.16B
109.42M
2.7%
74.24%
21.3%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO